Yatharth Hospital Achieves Record Quarterly Revenue, Declares Maiden Dividend

Yatharth Hospital & Trauma Care Services Ltd reported its highest-ever quarterly revenue of INR 3,927 million, marking a significant 51% year-on-year growth for the first quarter of FY27. The company also announced its maiden interim dividend of 5% of the face value, signaling strong financial confidence.

Reader Takeaway: Strong revenue growth driven by new asset integration; margin pressure from expansion is a key concern.

What Just Happened

The hospital chain posted a consolidated EBITDA of INR 917 million. While consolidated EBITDA margins stood at 23.3%, management highlighted an adjusted EBITDA margin of 28.1%, excluding the temporary impact from new facilities in New Delhi and Faridabad Sector 20. Profit After Tax (PAT) was INR 454 million.

Why This Matters

This strong revenue performance indicates successful ramp-up of newer facilities and effective operational management. The maiden dividend demonstrates the company's ability to generate sufficient profits and cash flows, potentially attracting more investors. The clear guidance on expansion targets provides a roadmap for future growth.

The Backstory

Established hospitals in Noida and Jhansi-Orchha contributed INR 2,862 million in revenue, growing 22% YoY, with occupancy around 75%. Newer facilities in Greater Faridabad, New Delhi, Faridabad Sector 20, and Agra added INR 1,067 million, making up 27% of total revenue. Key newer facilities like Faridabad Sector 20 achieved EBITDA breakeven within 9 months, and Agra delivered over 20% EBITDA margin in its first full quarter post-integration.

What Changes Now

The company reiterated its commitment to reaching a capacity of 5,000 beds, aiming for this milestone within the next 2.5 years. The Gurugram facility is scheduled to become operational in the first quarter of the next fiscal year. Management anticipates an annual Average Revenue Per Operating Bed (ARPOB) growth of 9-10%.

Risks to Watch

Investors should monitor the impact of aggressive expansion on EBITDA margins, as new hospitals are expected to take time to reach optimal profitability. Increased interest costs due to recent capex and acquisitions, such as the Gurugram facility, are also affecting short-term profits. There is also a sector-wide watch point regarding potential government recommendations to cap hospital room rents.

Peer Comparison

While specific peer comparison data is not in the filing, Yatharth Hospital's performance in integrating new assets and achieving breakeven milestones quickly showcases operational efficiency. The focus on premium ARPOB, exceeding INR 50,000 in NCR facilities, positions it well within the healthcare sector.

Context Metrics

• Group ARPOB reached an all-time high of INR 34,758, up 7% YoY.
• Capex per bed for future additions is projected between INR 75-80 lakhs, attributed to higher land prices, inflation, and superior equipment.

What to Track Next

Investors will be watching the ramp-up of the Gurugram facility and the progression of other expansion plans towards the 5,000-bed target. Continued improvement in EBITDA margins, especially the reduction of drag from newer assets, and the sustained growth in ARPOB will be key indicators.